RA than others. For instance, a graded distribution of RA has been reported in developmentally important regions Retinoic acid (RA) is a physiological agent that has a such as the ZPA area of the limb bud (Thaller and Eichele, wide range of biological activity and appears to regulate 1987) and Hensen's node (Chen et al., 1992) . Recently, developmental programs of vertebrates. However, little the role of RA has been examined more directly by is known about the molecular basis of its metabolism.
manipulating the RAR and RXR genes. These studies have
Here we have identified a novel cytochrome P450
clearly demonstrated the importance of these receptors in (P450 RA ) that specifically metabolizes RA. In vitro, development. As expected, mice deficient in RAR or RXR P450 RA converts all-trans RA into 5,8-epoxy all-trans show a variety of developmental defects (Kastner et al., 
RA. P450 RA metabolizes other biologically active RAs
1994; Lohnes et al., 1994) , which overlap with the phenosuch as 9-cis RA and 13-cis RA, but fails to metabolize type of the fetal vitamin A-deficiency syndrome. their precursors, retinol and retinal. Overexpression
In spite of extensive studies on RAR and RXR, surprisof P450 RA in cell culture renders the cells hyposensitive ingly little is known about the molecular basis of retinoid to all-trans RA. These functional tests in vitro and metabolism. The major sources of retinoids in the diet are in vivo indicate that P450 RA inactivates RA. The P450 RA provitamin A carotenoids and retinyl esters. Retinyl esters gene is not expressed uniformly but in a stage-and are enzymatically converted to retinol in the intestinal region-specific fashion during mouse development. The lumen before absorption, and carotenoids are converted major expression domains in developing embryos to retinol in enterocytes (Blomhoff et al., 1990) . RA may include the posterior neural plate and neural crest cells be synthesized by oxidizing retinol or directly from for cranial ganglia. The expression of P450 RA , however, β-carotene, but the metabolic pathway of RA synthesis, is not necessarily inducible by excess RA. These results isomerization and degradation has not been established suggest that P450 RA regulates the intracellular level of yet. In order to understand the physiological roles of RA,
Introduction
In this study, we have identified an RA-catabolizing enzyme, a novel cytochrome P450 which we refer to as Retinoic acid (RA) is a vitamin A derivative that has a P450 RA . Functional analysis in vivo and in vitro clearly remarkably wide range of biological activity, such as in demonstrated that P450 RA encodes an enzyme that cell growth, differentiation and morphogenesis (for specifically metabolizes RA to an inactive form. Interestreviews, see Mangelsdorf et al., 1994) . ingly, P450 RA is not expressed uniformly in embryos or RA exists endogenously in vertebrate embryos and adults. adult organs. Rather, P450 RA expression is found in Multiple forms of RA have been found in vivo, including restricted regions of developing embryos which are known all-trans RA (Thaller and Eichele, 1987; Durston et al., 1989) , 9-cis RA (Heyman et al., 1992; Levin et al., 1992;  to be sensitive to excess RA. We propose that P450 RA Fig. 1 . Expression of P450 RA in P19 cells, adult mouse organs and developing embryos. Poly(A) ϩ RNA (5-10 μg) from the indicated cells, adult organs or developing embryos was subjected to Northern blot analysis. The EcoRI-XhoI insert of a partial cDNA clone 10245 was used as a probe. d0, undifferentiated P19 cells; d2, d4 and d8, P19 cells 2, 4 and 8 days after RA induction, respectively. The integrity of each poly(A) ϩ RNA had been confirmed with a β-actin probe (data not shown).
may be a determinant that sets up the uneven distribution P450 RA metabolizes RA in vitro of RA during embryogenesis. The presence of such an For several reasons, we speculated that P450 RA might RA-inactivating enzyme further strengthens, from a new encode an enzyme which metabolized RA. First, a number point of view, the physiological importance of RA in of P450 genes are known to be inducible by their substrate establishing body plan as well as in homeostasis. (Nebert and Gonzalez, 1987; Gotoh and Fujii-Kuriyama, 1988) . In P19 cells, P450 RA appeared to be inducible by RA (as described below, however, the P450 RA gene is not
Results
necessarily inducible by RA). Secondly, P450 RA was closest to the CYP4 family, some members of which are P450 RA is a new member of the P450 superfamily known to metabolize linear molecules such as lipoic acid, P19 is a pluripotent embryonic carcinoma (EC) cell line prostaglandin and leukotriene (Kikuta et al., 1993 ; Roman that can differentiate to neural cell types when induced et al., 1993) . All-trans RA also contains a linear structure. with all-trans RA . By Finally, the involvement of cytochrome P450 in RA applying a sensitive subtraction procedure (Saijoh et al., metabolism has been suggested by previous pharmaco-1996) to the P19 cell system, we have isolated a number logical studies (Martini and Murray, 1993) . of genes whose expression is induced 2 days after RA We first tested whether P450 RA could metabolize allinduction (our unpublished results). One such clone (clone trans RA in vitro. 293T cells were transfected with a No. 10245; referred to as P450 RA below) was used in this P450 RA expression vector. Since P450 RA possesses a study. Northern blot analysis confirmed that P450 RA is not transmembrane domain typical of microsome-associated expressed in undifferentiated P19 cells, but is highly P450s, microsome fractions were prepared from transexpressed 2 days after RA treatment (Figure 1 ). The fected and untransfected cells. Microsome fractions were expression is transient: it reaches its maximum level incubated with various retinoids and the reaction products 4 days after the RA induction, but disappears on the were analyzed by HPLC. The microsomes from untranseighth day.
fected 293T cells did not metabolize all-trans RA (data P450 RA mRNA encodes an open reading frame of 497 not shown). In contrast, the microsomes from the transamino acid residues (Figure 2 ). The encoded amino acid fected 293T cells could convert all-trans RA into a new sequence showed significant homology to a number of form (peak X, Figure 3A ). The substrate specificity of P450 members, with the highest (25% identical overall) P450 RA was examined and it was found that P450 RA could homology to the CYP4 family. The carboxy-terminal also metabolize 9-cis RA ( Figure 3B ). This enzyme also region was more conserved than the amino-terminal region metabolized other retinoic acids such as 13-cis and 9,13-and includes a highly conserved cysteine residue (at amino di-cis RAs (data not shown). However, it failed to acid residue 442), which is a heme-binding site. The metabolize precursors of these RAs such as retinal, retinol amino-terminal region rich in hydrophobic residues is and β-carotene ( Figure 3C and D and data not shown), probably a transmembrane domain, a domain commonly which are not (or much less) potent with respect to found in microsome-associated P450s. In all, P450 RA is probably a diverged member of the P450 superfamily.
biological activity when compared with all-trans and 9-cis Identical amino acid residues are indicated by upper case letters. Amino acid residues conserved among more than three of the P450 members are boxed.
RAs. Next, we wanted to identify the enzymatic metabolite constitutive expression of P450 RA would have any effect on RA-induced differentiation of P19 cells. Undifferentiof all-trans RA. As only a small amount of the enzymatic metabolite (peak X in Figure 3A ) was available, we ated P19 cells were transformed with a P450 RA expression vector or a control vector resulting in P19R or P19C cells, chemically oxidized all-trans RA and searched for an oxidized compound that would show properties identical respectively. Northern blot analysis confirmed a high level of P450 RA expression in P19R cells but not in P19C to those of peak X. All-trans RA was oxidized with m-chloroperoxybenzoic acid and the oxidized compounds cells ( Figure 5A ). Both types of cells were induced to differentiate with various concentrations of all-trans RA, were separated by reverse phase HPLC ( Figure 4A ). One of the oxidized forms, peak 2, showed the same retention and cell differentiation was monitored by morphological observations ( Figure 5B) and by measuring the level time as that of the enzymatic metabolite (peak X) on HPLC ( Figure 4B ). It should be noted that peak 2 was of Oct-3 ( Figure 5C ), a transcription factor specific to undifferentiated cells (Okamoto et al., 1990 ; Okazawa clearly different from 4-oxo all-trans RA ( Figure 4B) . Peak 2 was then analyzed by means of gas chromatography/mass et al., 1991). As previously reported for P19 cells , P19C cells could respond spectroscopy (GC/MS) and was identified as 5,8-epoxy all-trans RA (peak 1 was identified as 5,6-epoxy all-trans to 10 -9 -10 -6 M all-trans RA. In contrast, P19R cells were hyposensitive to all-trans RA. They failed to respond to RA). Finally, peak 2 (5,8-epoxy all-trans RA) co-migrated with the enzymatic metabolite (peak X) on reverse phase 10 -9 and 10 -8 M all-trans RA and remained undifferentiated. With 10 -7 M all-trans RA, the majority of the cells HPLC ( Figure 4D ) and normal phase HPLC ( Figure 4E ). These results strongly suggest that peak X, an enzymatic differentiated into neural cells, but many colonies of undifferentiated cells still remained ( Figure 5B ). A concenmetabolite of all-trans RA, is 5,8-epoxy all-trans RA.
tration of 10 -6 M all-trans RA could induce all the cells to differentiate.
P450 RA inactivates RA in vivo
We next examined whether P450 RA could inactivate the Retinoic acid receptors can act as transcriptional activators in the presence of their ligands. In a second approach, biological activity of RA in vivo. First, we tested whether with 10 -9 M RA (Figure 6 ), which was consistent with the findings of a previous report (Brand et al., 1988) . In HeLa-R cells, on the other hand, RARβ failed to activate endoderm continue to express P450 RA . In addition, the embryonic (but not the extra-embryonic) mesoderm is the cat gene with 10 -9 M RA. In HeLa-R cells, an~100 times higher concentration of all-trans RA was required beginning to express the gene. The extra-embryonic ectoderm is positive for expression while the embryonic to obtain a comparable level of activation.
The results from the two approaches described above ectoderm is negative. A similar expression pattern can be seen at 7.25 d.p.c., but expression in mesoderm and indicate that P450 RA metabolizes all-trans RA into a biologically inactive form.
the primitive streak (excluding the node) becomes more evident ( Figure 7B and F). There is a postero-anterior gradient in the mesodermal expression ( Figure 7F ( Figure 7C and G). In the extra-embryonic region, only the endoderm is positive. This expression pattern disap-( Figure 7A and E), the extra-embryonic and embryonic Figure 7H ), which are probably migrating neural crest cells. Between 9.5 and 10.5 d.p.c., P450 RA is is highly expressed in a posterior region, including the caudal neural plate, tailbud mesoderm and hindgut endoexpressed mainly in two distinct regions: a posterior region (Region 1), including the caudal neural plate, hindgut and derm ( Figure 7D and data not shown). It is also expressed in an anterior region which includes the prospective tailbud mesoderm, and an anterior region (Region 2), including neural crest cells for cranial ganglia. At 9.5 rhombomere 2, foregut epithelium and the first branchial arch epithelium ( Figure 7D and H) . P450 RA -expressing d.p.c. (Figures 7I and 8A) , the anterior margin of Region 1 has regressed toward the posterior end. Expression in cells located in the ventrolateral region of the rhombomere can first be detected at the 5-6 somite stage (data not Region 1 can be found in the caudal neural plate as well as in the hindgut and tailbud mesoderm ( Figure 8G ). shown). The timing of their appearance and their location suggest that these cells are pre-migratory cranial crest Transverse sections of Region 2 indicate that it is clusters of neural crest cells for cranial ganglia V, VII/VIII and cells. P450 RA -expressing cells are also found at 8.5 d.p.c. in mesenchyme between the first branchial arch and IX/X that express P450 RA ( Figure 8C , E, I, K and M). It (Brand et al., 1988) in the presence of the indicated concentrations of all-trans RA. RA-dependent, RARβ-mediated transactivation of the cat gene was examined by measuring the CAT activity.
appears that, among cranial crest cells, only those of the were rather unexpected. The expression in Region 1 (the cranial ganglial lineage express P450 RA . At 10.5 d.p.c.
caudal neural plate, tailbud mesoderm and hindgut) was ( Figure 7J ), expression in Region 1 is detected only at the abolished or greatly reduced in 100% (8/8) of the RAtail end, while expression in Region 2 is still evident. treated embryos (Figure 8 ). Transverse sections confirmed Expression in Regions 1 and 2 almost disappears at 11.5 the presence of the neural plate and hindgut in the RAd.p.c. (Figure 7K ). Between 9.5 and 11.5 d.p.c., a weaker treated embryos ( Figure 8H ). On the other hand, the level of expression is detected in other regions such as expression in Region 2 was up-regulated by exogenous the forelimb bud, hindlimb bud, otic vesicle, eye and RA; not only did the expression level in the cranial maxilo-mandibular cleft ( Figure 7I-N) . In the developing ganglia increase, but the expression domain was extended eye, P450 RA is expressed in the dorsoventral boundary ( Figure 8B , D and F). The expression domain in the otic region of the neural retina ( Figure 7K and L). In the limb vesicle was also extended by excess RA. In control 9.5 buds, a weak level of expression is evenly detected in the d.p.c. embryos, P450 RA was expressed in the ventrolateral whole limb buds at 9.5 and 10.5 d.p.c. (Figure 7I and J) . region of the otic vesicle, which extended halfway from At 11.5 d.p.c., however, the expression is restricted to the its posterior end ( Figure 8I , K, M and O). In RA-treated interdigital space ( Figure 7K, M and N) . In addition, embryos, the expression domain shifted to the ventral P450 RA expression is found in a base region of the forelimb region (compare Figure 8M with N) and extended almost bud as a sharp line ( Figure 7K and M) but not in the entirely from the posterior end to the anterior end corresponding region of the hindlimb bud ( Figure 7N ).
( Figure 8J , L, N and P). Expression at later developmental stages was examined These results suggest that, unlike other P450s that by Northern blot analysis (Figure 1) The functional tests in vitro (Figures 3 and 4) and in vivo these cells differentiated into neural cells in response to (Figures 5 and 6) indicate that P450 RA catabolizes RA RA and cell aggregation. However, it was not certain and possesses substrate specificity. It can metabolize whether induction of P450 RA was a consequence of RA biologically active retinoids such as all-trans and 9-cis treatment or of the differentiation into a neural cell lineage.
RAs, whereas it fails to recognize their precursors such as Therefore, we next examined whether P450 RA expression β-carotene, all-trans retinol and all-trans retinal (Figure 3 ), can be induced by RA in mouse embryo.
which are known to be much less active. It appears that All-trans RA or vehicle alone was administered orally several different stereoisomers of RA can be the substrate to pregnant mice at 8.5 and 9.0 d.p.c. P450 RA expression in the embryos was examined at 9.5 d.p.c. The results for this enzyme, and the presence of the carboxy-terminus , first branchial arch; cn, caudal neural plate; e, eye; ee, embryonic ectoderm; em, embryonic mesoderm; fg, foregut; fl, forelimb bud; h, heart; hl, hindlimb bud; nc, neural crest cells for cranial ganglia; no, node; ot, otic vesicle; ps, primitive streak; rh, future rhombomere 2. . In order to avoid non-specific accumulation of reagents in the neural tube and to demonstrate clearly the differences in expression pattern between RA-treated and vehicle-alone embryos, the neural tube of these embryos was opened. Administration of vehicle alone had no effect on P450 RA expression (data not shown). (O and P) Schematic representation of P450 RA expression in the otic vesicle viewed from the ventral side. The differences in the expression pattern between control (O) and RA-treated (P) embryos are summarized. Note that the expression domain (shown in blue) is extended in the RA-treated embryo. Abbreviations: A, anterior; P, posterior; Lat., lateral; Med., medial; ba, branchial artery; b1, b2, and b3, first, second and third branchial archs; g, hindgut; n, notochord; np, neural plate; nt, neural tube; op, optic vesicle; ot, otic vesicle; p, primary head vein; r, Rathke's pouch; V, trigeminal neural crest cells; VII/VIII, facio-acoustic neural crest cells; IX/X, glossopharyngeal-vagal neural crest cells.
is essential. It remains to be seen exactly what structure(s) of active RA in P450 RA -expressing cells would be lower than that in non-expressing cells. If this is the case, the is recognized by P450 RA .
The chemical analysis (Figure 4 ) indicated that the region-specific expression of P450 RA should result in uneven distribution of active RA in embryos. Our results enzymatic metabolite of all-trans RA (peak X in Figure 3A ) was 5,8-epoxy all-trans RA. In previous (Figures 5 and 6 ) suggest that P450 RA -expressing P19 and HeLa cells can metabolize 0.01-0.1 μ M of all-trans RA pharmacological studies by others (Barua et al., 1991) , all-trans RA was injected into adult animals and its in vivo present in the culture medium. Endogenous all-trans RA and 9-cis RA are present at~10 -8 M in embryos and adult metabolites were characterized. The major metabolites of all-trans RA included 4-hydroxy all-trans RA and 5,6-organs (Thaller and Eichele, 1987; Durston et al., 1989; Heyman et al., 1992) . Therefore, these P450 RA -expressing epoxy all-trans RA which are much less active forms (Reynold et al., 1993) . However, 5,8-epoxy all-trans RA cells are capable of metabolizing physiological levels of RA. was not the major metabolite detected in vivo. There are several explanations for this discrepancy. First, 5, Alternatively, one may argue that expression of P450 RA is a protective response to a high concentration of RA, all-trans RA may exist in vivo as a transient intermediate which is converted rapidly to other forms (such as 5,6-i.e. regional concentration of RA would be determined by some other mechanism not involving P450 RA , and P450 RA epoxy all-trans RA). Secondly, it has been shown that 5,6-epoxy all-trans RA can be converted to 5,8-epoxy allis expressed in Regions 1 and 2 simply because the RA concentration in these regions is relatively high. However, trans RA in vitro by the acidic conditions used for RA extraction (McCormick et al., 1978) . It is possible that our data suggest that this is not the case. The P450 RA gene is not necessarily inducible by an increasing concenthe true metabolite of all-trans RA produced by P450 RA was 5,6-epoxy all-trans RA instead of 5,8-epoxy all-trans tration of RA; in Region 1, it can in fact be repressed by excess RA ( Figure 8B and H). At least the expression in RA. However, the enzymatic metabolite was 5,8-epoxy all-trans RA even when the reaction mixture was extracted Region 1 should not be a consequence of a high RA concentration in that region. Therefore, we would propose under non-acidic conditions (data not shown). Finally, P450 RA may be the major RA-catabolizer in developing that P450 RA may be a determinant of the regional concentration of active RA in developing embryos. embryos, but may not be the major one in adults. However, expression of P450 RA in adult liver (Figure 1 ) argues against this possibility.
Role of the P450 RA gene in development
In post-implantation embryos between 9.5 and 10.5 d.p.c., Very recently, White et al. (1996) reported a new P450 from zebrafish (referred to as P450RAI) that can P450 RA is expressed mainly in two regions: Region 1 (the caudal neural plate, hindgut and tailbud mesoderm) and metabolize RA. The amino acid sequence of P450RAI shows significant homology to that of our P450 RA (~60% Region 2 (neural crest cells for the cranial ganglia). It may be that the level of RA in these regions needs to be of the amino acid residues are identical). However, these two P450s have different activities: P450RAI metabolizes kept low for their normal development. In this regard, it is interesting to note that RARα and RARβ are expressed all-trans RA to 4-oxo and 4-hydroxy all-trans RA whereas P450 RA metabolizes all-trans RA to 5,8-epoxy all-trans in the closed neural tube but not in the neural plate of the caudal neuropore (Ruberte et al., 1991) . Thus, RA-RA (Figure 4 ). For many RA-regulated activities (such as binding to RAR and teratogenic effects on Xenopus mediated action may be absent in Region 1. Furthermore, it is an interesting coincidence that those P450 RA -expressing embryos), 4-oxo all-trans RA is as potent as all-trans RA (Pijnappel et al., 1993) . In this regard, it is most likely regions are known to be highly sensitive to excess RA. When embryos are challenged by excess all-trans RA at that P450 RA and P450RAI have a distinct role in RA metabolism: while P450 RA catabolizes biologically potent 8.5 d.p.c., it alters the migration pattern and identity of neural crest cells for cranial ganglia (Lee et al., 1995) . RAs, P450RAI may be involved in the production of active metabolites with functions different from those of Excess RA also causes underdevelopment of the posterior neural tube, which will very often result in spina bifida at all-trans RA. a later stage (Yasuda et al., 1990) . The response of the P450 RA gene to exogenous RA observed in Region 1 P450 RA may regulate the regional concentration of RA in embryos would explain why the posterior neuropore is particularly sensitive to exogenous RA. Since P450 RA expression in It has been suggested that biologically active RAs are distributed unevenly in vertebrate embryos. For example, Region 1 is repressed by exogenous RA, Region 1 (where the RA level is normally kept low) would be the site the posterior part of the limb bud and Hensen's node appear to contain more RA than their neighboring regions where the intracellular RA concentration increases most dramatically. The elevated level of RA probably interferes (Thaller and Eichele, 1987; Chen et al., 1992 ). It appears that some cells contain more RA than others. If so, what with the normal development of the caudal neural plate. Recent studies on mice deficient in RAR/RXR have mechanism can account for the uneven distribution of RA in embryos? Formally there are several possibilities; the clearly demonstrated the importance of these receptors in development (Kastner et al., 1994; Lohnes et al., 1994) . cellular uptake of RA or the rate of its synthesis/degradation may vary between each cell type. However, there However, in a strict sense, it has not been firmly established that all the actions of RA are mediated by the nuclear RA has been no direct evidence supporting any of these possibilities. In this study, we have provided several lines receptors alone: there may be a mechanism not involving RAR/RXR. This is a difficult question to address since it of evidence indicating that P450 RA can convert biologically active forms of RA (such as all-trans and 9-cis RA) into would be impossible to deplete endogenous RA. In this regard, the P450 RA gene may serve as a very useful tool an inactive form(s). Thus, one can envisage that the level Retinoids were then extracted from the reaction mixture, concentrated and analyzed by reverse phase HPLC as described previously (Kojima resulted in malformation of many organs (our unpubet al., 1994) . The retinoids were detected at a wavelength of 350 nm.
lished data).
Standard retinoids were used as described previously (Kojima et al., 1994) .
Role of the P450 RA gene in the adult
In the adult, P450 RA was expressed only in the liver,
Chemical analysis of RAs
which resembles the expression pattern of other P450
Reverse phase HPLC analysis of RA isomers was performed as previously described (Kojima et al., 1994) . Normal phase HPLC analysis was done genes including those involved in the metabolism of with a Wakosil-II 5C18AR column (2ϫ25 cm) eluted with methanolxenobiotics. P450 RA present in adult liver may be required all-trans RA leads to remission, most patients later develop CAT assay RA resistance. As previously proposed (Kizaki et al., HeLa cells were transfected with 2.5 μg of pEFneo-P450 RA and 25 μg 1996), a P450 molecule such as P450 RA may be involved of pBOS-P450 RA and stable transformants were selected with 400 μg/ in the development of such RA resistance. ml of G418. More than 10 3 G418-resistant colonies were pooled, and were referred to as HeLa-R. For the CAT assay, HeLa and HeLa-R cells were transfected with 5 μg of pRARE-Tkcat, 1 μg of RARβ expression
Materials and methods
vector (pSGRARβ; Brand et al., 1988 ) and 3 μg of pEFLacZ as an internal standard. Various concentrations of all-trans RA were added to Isolation of the P450 RA gene the culture medium after transfection. Cells were harvested 48 h after A cDNA library was constructed from P19 cells at 2 days after RA transfection for CAT assay. induction. A number of cDNA clones whose expression was activated 2 days after RA induction were isolated by a sensitive subtraction procedure (Saijoh et al., 1996) . One such clone was 10245. The same
